“Mrs Osborne, 80, is the first of 10 patients with AMD taking part in a trial of the gene therapy treatment, manufactured by Gyroscope Therapeutics, funded by Syncona, the Wellcome Trust founded investment firm.”
Benitec would obviously be feeling the heat a little. Still waiting for new on this one, personally.
- Forums
- ASX - By Stock
- AMD
“Mrs Osborne, 80, is the first of 10 patients with AMD taking...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)